Co-morbidity in the severely mentally Ill

Cardiometabolic risk factors, prevention and intervention

H. L. Millar, Ihsan M Salloum, M. T. Abou-Saleh

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Co-morbidity represents one of the greatest challenges for twenty-first-century medicine. A high prevalence of co-morbidity in the severely mentally ill (SMI) has been well established leading to a significant impact on quality of life, life expectancy and premature death by 15-20 years. The major recognised contributor to excess death is cardiovascular disease. Known risk factors include smoking, obesity, alcohol and drug misuse and diabetes. The field of knowledge of the linkage between common psychiatric disorders and cardiometabolic risk is growing with a focus on common pathophysiological and inflammatory processes in addition to the already well-recognised cluster of risk factors which have been described in the past as 'metabolic syndrome'. International/national guidelines and consensus statements provide the guidance and evidence to optimise screening for and management of risk factors with increasing emphasis on early intervention with lifestyle changes and treatment review. In this chapter, we have prepared a narrative review of the relevant literature complimented by the authors' experience of providing holistic care for the SMI. Also we refer to the evidence for shared pathophysiological mechanisms and cardiometabolic risk factors contributing to the high levels of co-morbidity in this population. Finally we make recommendations for screening and treatment outlining effective interventions to improve quality of life and life expectancy.

Original languageEnglish (US)
Title of host publicationAdvances in Psychiatry
PublisherSpringer International Publishing
Pages79-102
Number of pages24
ISBN (Electronic)9783319705545
ISBN (Print)9783319705538
DOIs
StatePublished - Aug 7 2018

Fingerprint

Mentally Ill Persons
Morbidity
Life Expectancy
Quality of Life
Premature Mortality
Psychiatry
Life Style
Consensus
Cardiovascular Diseases
Obesity
Smoking
Alcohols
Medicine
Guidelines
Therapeutics
Pharmaceutical Preparations
Population

ASJC Scopus subject areas

  • Medicine(all)
  • Psychology(all)

Cite this

Millar, H. L., Salloum, I. M., & Abou-Saleh, M. T. (2018). Co-morbidity in the severely mentally Ill: Cardiometabolic risk factors, prevention and intervention. In Advances in Psychiatry (pp. 79-102). Springer International Publishing. https://doi.org/10.1007/978-3-319-70554-5_5

Co-morbidity in the severely mentally Ill : Cardiometabolic risk factors, prevention and intervention. / Millar, H. L.; Salloum, Ihsan M; Abou-Saleh, M. T.

Advances in Psychiatry. Springer International Publishing, 2018. p. 79-102.

Research output: Chapter in Book/Report/Conference proceedingChapter

Millar, HL, Salloum, IM & Abou-Saleh, MT 2018, Co-morbidity in the severely mentally Ill: Cardiometabolic risk factors, prevention and intervention. in Advances in Psychiatry. Springer International Publishing, pp. 79-102. https://doi.org/10.1007/978-3-319-70554-5_5
Millar HL, Salloum IM, Abou-Saleh MT. Co-morbidity in the severely mentally Ill: Cardiometabolic risk factors, prevention and intervention. In Advances in Psychiatry. Springer International Publishing. 2018. p. 79-102 https://doi.org/10.1007/978-3-319-70554-5_5
Millar, H. L. ; Salloum, Ihsan M ; Abou-Saleh, M. T. / Co-morbidity in the severely mentally Ill : Cardiometabolic risk factors, prevention and intervention. Advances in Psychiatry. Springer International Publishing, 2018. pp. 79-102
@inbook{5db9ecc010a84884ba3056f725a1328f,
title = "Co-morbidity in the severely mentally Ill: Cardiometabolic risk factors, prevention and intervention",
abstract = "Co-morbidity represents one of the greatest challenges for twenty-first-century medicine. A high prevalence of co-morbidity in the severely mentally ill (SMI) has been well established leading to a significant impact on quality of life, life expectancy and premature death by 15-20 years. The major recognised contributor to excess death is cardiovascular disease. Known risk factors include smoking, obesity, alcohol and drug misuse and diabetes. The field of knowledge of the linkage between common psychiatric disorders and cardiometabolic risk is growing with a focus on common pathophysiological and inflammatory processes in addition to the already well-recognised cluster of risk factors which have been described in the past as 'metabolic syndrome'. International/national guidelines and consensus statements provide the guidance and evidence to optimise screening for and management of risk factors with increasing emphasis on early intervention with lifestyle changes and treatment review. In this chapter, we have prepared a narrative review of the relevant literature complimented by the authors' experience of providing holistic care for the SMI. Also we refer to the evidence for shared pathophysiological mechanisms and cardiometabolic risk factors contributing to the high levels of co-morbidity in this population. Finally we make recommendations for screening and treatment outlining effective interventions to improve quality of life and life expectancy.",
author = "Millar, {H. L.} and Salloum, {Ihsan M} and Abou-Saleh, {M. T.}",
year = "2018",
month = "8",
day = "7",
doi = "10.1007/978-3-319-70554-5_5",
language = "English (US)",
isbn = "9783319705538",
pages = "79--102",
booktitle = "Advances in Psychiatry",
publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Co-morbidity in the severely mentally Ill

T2 - Cardiometabolic risk factors, prevention and intervention

AU - Millar, H. L.

AU - Salloum, Ihsan M

AU - Abou-Saleh, M. T.

PY - 2018/8/7

Y1 - 2018/8/7

N2 - Co-morbidity represents one of the greatest challenges for twenty-first-century medicine. A high prevalence of co-morbidity in the severely mentally ill (SMI) has been well established leading to a significant impact on quality of life, life expectancy and premature death by 15-20 years. The major recognised contributor to excess death is cardiovascular disease. Known risk factors include smoking, obesity, alcohol and drug misuse and diabetes. The field of knowledge of the linkage between common psychiatric disorders and cardiometabolic risk is growing with a focus on common pathophysiological and inflammatory processes in addition to the already well-recognised cluster of risk factors which have been described in the past as 'metabolic syndrome'. International/national guidelines and consensus statements provide the guidance and evidence to optimise screening for and management of risk factors with increasing emphasis on early intervention with lifestyle changes and treatment review. In this chapter, we have prepared a narrative review of the relevant literature complimented by the authors' experience of providing holistic care for the SMI. Also we refer to the evidence for shared pathophysiological mechanisms and cardiometabolic risk factors contributing to the high levels of co-morbidity in this population. Finally we make recommendations for screening and treatment outlining effective interventions to improve quality of life and life expectancy.

AB - Co-morbidity represents one of the greatest challenges for twenty-first-century medicine. A high prevalence of co-morbidity in the severely mentally ill (SMI) has been well established leading to a significant impact on quality of life, life expectancy and premature death by 15-20 years. The major recognised contributor to excess death is cardiovascular disease. Known risk factors include smoking, obesity, alcohol and drug misuse and diabetes. The field of knowledge of the linkage between common psychiatric disorders and cardiometabolic risk is growing with a focus on common pathophysiological and inflammatory processes in addition to the already well-recognised cluster of risk factors which have been described in the past as 'metabolic syndrome'. International/national guidelines and consensus statements provide the guidance and evidence to optimise screening for and management of risk factors with increasing emphasis on early intervention with lifestyle changes and treatment review. In this chapter, we have prepared a narrative review of the relevant literature complimented by the authors' experience of providing holistic care for the SMI. Also we refer to the evidence for shared pathophysiological mechanisms and cardiometabolic risk factors contributing to the high levels of co-morbidity in this population. Finally we make recommendations for screening and treatment outlining effective interventions to improve quality of life and life expectancy.

UR - http://www.scopus.com/inward/record.url?scp=85063047407&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063047407&partnerID=8YFLogxK

U2 - 10.1007/978-3-319-70554-5_5

DO - 10.1007/978-3-319-70554-5_5

M3 - Chapter

SN - 9783319705538

SP - 79

EP - 102

BT - Advances in Psychiatry

PB - Springer International Publishing

ER -